After treatment, the mice’s memories were essentially shunted back into a younger state. The researchers found that reprogrammed engrams displayed molecular behavior of more youthful cells. Using a ...
Alzheimer’s disease has long been a diagnosis that arrives only after memory begins to fray, by which time brain damage is already extensive. A new experimental drug called NU-9 is challenging that ...
New research suggests Alzheimer’s memory loss may be linked to disruptions in the brain’s replay mode. Here's how sleep, hippocampus function, and memory consolidation play a role in cognitive decline ...
New research suggests Alzheimer’s may start far earlier than previously thought, driven by a hidden toxic protein in the brain. Scientists found that an experimental drug, NU-9, blocks this early ...